3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Lung Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostate Adenocarcinoma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Breast Carcinoma In Situ
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Gemcitabine
19
Cisplatin
11
Capecitabine
9
Oxaliplatin
7
Fluorouracil
5
pembrolizumab
4
Leucovorin
4
Sorafenib
3
Magnetic Resonance Spectroscopy
3
Erlotinib Hydrochloride
3
trifluridine tipiracil drug combination
2
regorafenib
2
cobimetinib
2
atezolizumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Platinum
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Biopsy
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
varlilumab
1
vandetanib
1
tucatinib
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gallbladder Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
No trials found.